Author

Roberto A. Leon Ferre

Observed name: Roberto A Leon Ferre

Institutions: Mayo Clinic, Mayo Clinic Comprehensive Cancer Center (Minnesota)

Observed institutions: Mayo Clinic, Mayo Clinic Comprehensive Cancer Center (Minnesota)

OpenAlex ID: A5040014484

Apixaban and dalteparin in active malignancy‐associated venous thromboembolism: The ADAM VTE trial

2019 · Robert D. McBane, Waldemar E. Wysokinski, et al. · Journal of Thrombosis and Haemostasis · 592

Clinical management of metastatic hormone receptor-positive, HER2-negative breast cancer (MBC) after CDK 4/6 inhibitors: a retrospective single-institution study

2022 · Grace M. Choong, Savannah Liddell, et al. · Breast Cancer Research and Treatment · 21

The impact of coadministration of venlafaxine, citalopram or gabapentin on the metabolic activation of tamoxifen

2025 · Stephanie L. Safgren, Vera J. Suman, et al. · Breast Cancer Research and Treatment · 3

Abstract PS16-01: Intra-epithelial tumor immune landscapes are associated with clinical outcomes in early-stage triple-negative breast cancer

2021 · Jodi M Carter, Saranya Chumsri, et al. · Cancer Research · 2

Abstract 3119: Comparison of circulating tumor cell (CTC) derived DNA and circulating cell-free DNA (cfDNA) from simultaneous blood sampling of patients with metastatic breast cancer (MBC)

2020 · Minetta C. Liu, Karthik V. Giridhar, et al. · Cancer Research · 2

Reply to On the proportion of male breast cancer among all breast cancers

2020 · Siddhartha Yadav, Dhauna Karam, et al. · Cancer · 2

Works count: 6

Citation count: 622

H-index: 3

I10-index: 2